![LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41590-018-0217-9/MediaObjects/41590_2018_217_Fig4_HTML.png)
LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology
![LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41590-018-0217-9/MediaObjects/41590_2018_217_Fig3_HTML.png)
LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology
![LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41590-018-0217-9/MediaObjects/41590_2018_217_Fig1_HTML.png)
LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology
![Characterization of LAG-3, CTLA-4, and CD8 + TIL density and their joint influence on the prognosis of patients with esophageal squamous cell carcinoma - Wang - Annals of Translational Medicine Characterization of LAG-3, CTLA-4, and CD8 + TIL density and their joint influence on the prognosis of patients with esophageal squamous cell carcinoma - Wang - Annals of Translational Medicine](https://cdn.amegroups.cn/journals/amepc/files/journals/16/articles/32901/public/32901-PB9-1317-R1.png/w300)
Characterization of LAG-3, CTLA-4, and CD8 + TIL density and their joint influence on the prognosis of patients with esophageal squamous cell carcinoma - Wang - Annals of Translational Medicine
![LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41590-018-0217-9/MediaObjects/41590_2018_217_Fig2_HTML.png)
LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology
![LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41590-018-0217-9/MediaObjects/41590_2018_217_Fig8_HTML.png)
LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology
![A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses - ScienceDirect A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211383519309177-gr2.jpg)
A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses - ScienceDirect
![LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41590-018-0217-9/MediaObjects/41590_2018_217_Fig5_HTML.png)
LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII | Nature Immunology
![A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses - ScienceDirect A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211383519309177-gr8.jpg)